annual D&A:
$1.39B-$352.00M(-20.17%)Summary
- As of today (August 26, 2025), ELV annual depreciation & amortization is $1.39 billion, with the most recent change of -$352.00 million (-20.17%) on December 31, 2024.
- During the last 3 years, ELV annual D&A has risen by +$91.00 million (+6.99%).
- ELV annual D&A is now -20.17% below its all-time high of $1.75 billion, reached on December 31, 2023.
Performance
ELV Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$380.00M+$7.00M(+1.88%)Summary
- As of today (August 26, 2025), ELV quarterly depreciation & amortization is $380.00 million, with the most recent change of +$7.00 million (+1.88%) on June 30, 2025.
- Over the past year, ELV quarterly D&A has increased by +$45.00 million (+13.43%).
- ELV quarterly D&A is now -22.69% below its all-time high of $491.50 million, reached on June 30, 2015.
Performance
ELV quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$1.48B+$45.00M(+3.14%)Summary
- As of today (August 26, 2025), ELV TTM depreciation & amortization is $1.48 billion, with the most recent change of +$45.00 million (+3.14%) on June 30, 2025.
- Over the past year, ELV TTM D&A has dropped by -$36.00 million (-2.37%).
- ELV TTM D&A is now -18.64% below its all-time high of $1.82 billion, reached on June 30, 2023.
Performance
ELV TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ELV Depreciation and amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.2% | +13.4% | -2.4% |
| 3 y3 years | +7.0% | -3.3% | +1.2% |
| 5 y5 years | +22.9% | +32.9% | +34.2% |
ELV Depreciation and amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -20.2% | +7.0% | -19.7% | +15.5% | -18.6% | +6.3% |
| 5 y | 5-year | -20.2% | +22.9% | -19.7% | +34.8% | -18.6% | +34.2% |
| alltime | all time | -20.2% | +787.3% | -22.7% | +1401.4% | -18.6% | +2547.6% |
ELV Depreciation and amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $380.00M(+1.9%) | $1.48B(+3.1%) |
| Mar 2025 | - | $373.00M(-6.3%) | $1.44B(+3.0%) |
| Dec 2024 | $1.39B(-20.2%) | $398.00M(+21.0%) | $1.39B(-1.8%) |
| Sep 2024 | - | $329.00M(-1.8%) | $1.42B(-6.4%) |
| Jun 2024 | - | $335.00M(+1.2%) | $1.52B(-6.1%) |
| Mar 2024 | - | $331.00M(-21.9%) | $1.61B(-7.5%) |
| Dec 2023 | $1.75B(+4.2%) | $424.00M(-0.5%) | $1.75B(-2.7%) |
| Sep 2023 | - | $426.00M(-1.6%) | $1.79B(-1.4%) |
| Jun 2023 | - | $433.00M(-6.3%) | $1.82B(+2.2%) |
| Mar 2023 | - | $462.00M(-2.3%) | $1.78B(+6.2%) |
| Dec 2022 | $1.68B(+28.6%) | $473.00M(+4.9%) | $1.68B(+7.2%) |
| Sep 2022 | - | $451.00M(+14.8%) | $1.56B(+6.8%) |
| Jun 2022 | - | $393.00M(+9.8%) | $1.46B(+6.1%) |
| Mar 2022 | - | $358.00M(-0.6%) | $1.38B(+5.8%) |
| Dec 2021 | $1.30B(+12.8%) | $360.00M(+2.6%) | $1.30B(+5.7%) |
| Sep 2021 | - | $351.00M(+13.6%) | $1.23B(+3.6%) |
| Jun 2021 | - | $309.00M(+9.6%) | $1.19B(+2.0%) |
| Mar 2021 | - | $282.00M(-2.8%) | $1.17B(+1.0%) |
| Dec 2020 | $1.15B(+1.9%) | $290.00M(-5.8%) | $1.15B(+4.0%) |
| Sep 2020 | - | $308.00M(+7.7%) | $1.11B(+0.6%) |
| Jun 2020 | - | $286.00M(+5.9%) | $1.10B(-1.0%) |
| Mar 2020 | - | $270.00M(+9.8%) | $1.11B(-1.7%) |
| Dec 2019 | $1.13B(+0.1%) | $246.00M(-18.3%) | $1.13B(-3.6%) |
| Sep 2019 | - | $301.00M(+1.3%) | $1.18B(+1.1%) |
| Jun 2019 | - | $297.00M(+2.8%) | $1.16B(+1.0%) |
| Mar 2019 | - | $289.00M(+0.3%) | $1.15B(+1.7%) |
| Dec 2018 | $1.13B(+27.1%) | $288.00M(-0.1%) | $1.13B(+5.6%) |
| Sep 2018 | - | $288.30M(+0.8%) | $1.07B(+6.4%) |
| Jun 2018 | - | $286.00M(+6.0%) | $1.01B(+7.2%) |
| Mar 2018 | - | $269.70M(+18.5%) | $939.40M(+5.5%) |
| Dec 2017 | $890.40M(-2.3%) | $227.50M(+1.8%) | $890.40M(-0.5%) |
| Sep 2017 | - | $223.40M(+2.1%) | $895.30M(-0.5%) |
| Jun 2017 | - | $218.80M(-0.9%) | $900.20M(-0.8%) |
| Mar 2017 | - | $220.70M(-5.0%) | $907.20M(-0.5%) |
| Dec 2016 | $911.80M(+0.4%) | $232.40M(+1.8%) | $911.80M(+0.1%) |
| Sep 2016 | - | $228.30M(+1.1%) | $910.70M(+39.4%) |
| Jun 2016 | - | $225.80M(+0.2%) | $653.20M(-28.9%) |
| Mar 2016 | - | $225.30M(-2.6%) | $918.90M(+1.2%) |
| Dec 2015 | $907.90M(+6.7%) | $231.30M(-892.1%) | $907.90M(+2.6%) |
| Sep 2015 | - | -$29.20M(-105.9%) | $884.70M(-21.5%) |
| Jun 2015 | - | $491.50M(+129.4%) | $1.13B(+32.9%) |
| Mar 2015 | - | $214.30M(+3.0%) | $848.60M(-0.3%) |
| Dec 2014 | $851.00M | $208.10M(-2.5%) | $851.00M(-3.4%) |
| Sep 2014 | - | $213.50M(+0.4%) | $880.60M(-2.0%) |
| Jun 2014 | - | $212.70M(-1.8%) | $898.20M(-1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2014 | - | $216.70M(-8.8%) | $913.50M(+0.5%) |
| Dec 2013 | $908.80M(+22.7%) | $237.70M(+2.9%) | $908.80M(+5.2%) |
| Sep 2013 | - | $231.10M(+1.4%) | $864.20M(+5.4%) |
| Jun 2013 | - | $228.00M(+7.5%) | $820.00M(+5.9%) |
| Mar 2013 | - | $212.00M(+9.8%) | $774.00M(+4.5%) |
| Dec 2012 | $740.70M(+16.2%) | $193.10M(+3.3%) | $740.70M(+1.8%) |
| Sep 2012 | - | $186.90M(+2.7%) | $727.40M(+5.1%) |
| Jun 2012 | - | $182.00M(+1.8%) | $692.40M(+4.1%) |
| Mar 2012 | - | $178.70M(-0.6%) | $665.20M(+4.4%) |
| Dec 2011 | $637.20M(+6.1%) | $179.80M(+18.4%) | $637.20M(+3.5%) |
| Sep 2011 | - | $151.90M(-1.9%) | $615.70M(-0.6%) |
| Jun 2011 | - | $154.80M(+2.7%) | $619.60M(+1.2%) |
| Mar 2011 | - | $150.70M(-4.8%) | $612.00M(+1.9%) |
| Dec 2010 | $600.80M(+8.5%) | $158.30M(+1.6%) | $600.80M(+3.7%) |
| Sep 2010 | - | $155.80M(+5.8%) | $579.60M(+3.0%) |
| Jun 2010 | - | $147.20M(+5.5%) | $562.90M(+1.0%) |
| Mar 2010 | - | $139.50M(+1.8%) | $557.30M(+0.7%) |
| Dec 2009 | $553.50M(-3.2%) | $137.10M(-1.4%) | $553.50M(+0.4%) |
| Sep 2009 | - | $139.10M(-1.8%) | $551.20M(-1.4%) |
| Jun 2009 | - | $141.60M(+4.3%) | $558.90M(-0.7%) |
| Mar 2009 | - | $135.70M(+0.7%) | $562.70M(-1.6%) |
| Dec 2008 | $571.70M(-2.5%) | $134.80M(-8.2%) | $571.70M(-1.6%) |
| Sep 2008 | - | $146.80M(+1.0%) | $581.00M(+0.0%) |
| Jun 2008 | - | $145.40M(+0.5%) | $580.80M(-1.0%) |
| Mar 2008 | - | $144.70M(+0.4%) | $586.80M(+0.1%) |
| Dec 2007 | $586.20M(-3.1%) | $144.10M(-1.7%) | $586.20M(-1.8%) |
| Sep 2007 | - | $146.60M(-3.2%) | $596.80M(-0.8%) |
| Jun 2007 | - | $151.40M(+5.1%) | $601.80M(+0.2%) |
| Mar 2007 | - | $144.10M(-6.9%) | $600.60M(-0.7%) |
| Dec 2006 | $604.90M(-4.6%) | $154.70M(+2.0%) | $604.90M(-0.3%) |
| Sep 2006 | - | $151.60M(+0.9%) | $606.70M(-0.8%) |
| Jun 2006 | - | $150.20M(+1.2%) | $611.90M(-4.1%) |
| Mar 2006 | - | $148.40M(-5.2%) | $638.10M(+0.7%) |
| Dec 2005 | $633.80M(+127.1%) | $156.50M(-0.2%) | $633.80M(-4.1%) |
| Sep 2005 | - | $156.80M(-11.1%) | $661.10M(+38.3%) |
| Jun 2005 | - | $176.40M(+22.4%) | $478.10M(+31.2%) |
| Mar 2005 | - | $144.10M(-21.6%) | $364.40M(+30.6%) |
| Dec 2004 | $279.10M(+13.9%) | $183.80M(-801.5%) | $279.10M(+192.9%) |
| Sep 2004 | - | -$26.20M(-141.8%) | $95.30M(-21.6%) |
| Jun 2004 | - | $62.70M(+6.6%) | $121.50M(+106.6%) |
| Mar 2004 | - | $58.80M(+5.0%) | $58.80M(-62.5%) |
| Dec 2003 | $245.00M(+56.1%) | - | - |
| Dec 2002 | $157.00M | $56.00M(+24.2%) | $157.00M(+55.4%) |
| Sep 2002 | - | $45.10M(-19.3%) | $101.00M(+80.7%) |
| Jun 2002 | - | $55.90M | $55.90M |
FAQ
- What is Elevance Health, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Elevance Health, Inc.?
- What is Elevance Health, Inc. annual D&A year-on-year change?
- What is Elevance Health, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Elevance Health, Inc.?
- What is Elevance Health, Inc. quarterly D&A year-on-year change?
- What is Elevance Health, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Elevance Health, Inc.?
- What is Elevance Health, Inc. TTM D&A year-on-year change?
What is Elevance Health, Inc. annual depreciation & amortization?
The current annual D&A of ELV is $1.39B
What is the all time high annual D&A for Elevance Health, Inc.?
Elevance Health, Inc. all-time high annual depreciation & amortization is $1.75B
What is Elevance Health, Inc. annual D&A year-on-year change?
Over the past year, ELV annual depreciation & amortization has changed by -$352.00M (-20.17%)
What is Elevance Health, Inc. quarterly depreciation & amortization?
The current quarterly D&A of ELV is $380.00M
What is the all time high quarterly D&A for Elevance Health, Inc.?
Elevance Health, Inc. all-time high quarterly depreciation & amortization is $491.50M
What is Elevance Health, Inc. quarterly D&A year-on-year change?
Over the past year, ELV quarterly depreciation & amortization has changed by +$45.00M (+13.43%)
What is Elevance Health, Inc. TTM depreciation & amortization?
The current TTM D&A of ELV is $1.48B
What is the all time high TTM D&A for Elevance Health, Inc.?
Elevance Health, Inc. all-time high TTM depreciation & amortization is $1.82B
What is Elevance Health, Inc. TTM D&A year-on-year change?
Over the past year, ELV TTM depreciation & amortization has changed by -$36.00M (-2.37%)